|
Hall, Brian; Burnett, Andrea; Christians, Alicia et al. (2010) Thermodynamics of peptide and non-peptide interactions with the human 5HT1a receptor. Pharmacology 86:6-14
|
|
Thiagaraj, Harish V; Ortiz, Thomas C; Devereaux Jr, Marvin C et al. (2007) Regulation of G proteins by human 5-HT1a receptor TM3/i2 and TM5/i3 loop peptides. Neurochem Int 50:109-18
|
|
Babcock, A Michael; Wright, J; Bjerkness, D et al. (2002) Effects of prior apparatus experience and novelty of testing environment on locomotor activity following MK-801. Physiol Behav 77:177-81
|
|
Ortiz, T C; Devereaux Jr, M C; Parker, K K (2000) Structural variants of a human 5-HT1a receptor intracellular loop 3 peptide. Pharmacology 60:195-202
|
|
Minnick, M F; Anderson, B E (2000) Bartonella interactions with host cells. Subcell Biochem 33:97-123
|
|
Fulgham, D L; Widhalm, S R; Martin, S et al. (1999) FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium 6:185-95
|
|
Babcock, A M; Liu, H; Paden, C M et al. (1999) In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity. J Neurosci Res 56:36-43
|
|
Battisti, J M; Smitherman, L S; Samuels, D S et al. (1998) Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1. Antimicrob Agents Chemother 42:2906-13
|
|
Hayataka, K; O'Connor, M F; Kinzler, N et al. (1998) A bioactive peptide from the transmembrane 5-intracellular loop 3 region of the human 5HT1a receptor. Biochem Cell Biol 76:657-60
|
|
Willis, C L; Wacker, D A; Bartlett, R D et al. (1997) Irreversible inhibition of high-affinity [3H]kainate binding by a novel photoactivatable analogue: (2'S,3'S,4'R)-2'-carboxy-4'-(2-diazo-1-oxo-3, 3,3-trifluoropropyl)-3'-pyrrolidinyl acetate. J Neurochem 68:1503-10
|
Showing the most recent 10 out of 16 publications
